Upstream Bio Upstream Bio is a clinical-stage biotechnology company that develops treatments for inflammatory diseases. | |||
Founding Date | Founding Date 2010 | Founding Date 2021 | Founding Date 2009 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations KR HQ | Locations Waltham, US HQ | Locations Burnaby, CA HQ Porto, PT Manchester, GB |
Employees | Employees N/A | Employees 38 | Employees N/A |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.3 b | Valuation ($) 401.7 k |
Financial | |||
Revenue (est.) | Revenue (est.) ₩2.3b (FY, 2024) | Revenue (est.) $2.9m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods (₩74.1m) (FY, 2024) | Cost of goods $23m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit ₩2.4b (FY, 2024) | Gross profit ($20.2m) (FY, 2025) | Gross profit N/A |
Net income | Net income (₩16.3b) (FY, 2024) | Net income ($143.4m) (FY, 2025) | Net income ($7.1m) (FY, 2022) |
Upstream Bio is a clinical-stage biotechnology company that develops treatments for inflammatory diseases.
View companyAlbert Labs is a clinical research and drug development company.
View company